Comparison of baseline characteristics of unresected, stage III NSCLC patients treated with systemic therapy, radiotherapy, and concurrent chemoradiotherapy1,2.
posted on 2020-03-18, 17:34authored byPriyanka Bobbili, Kellie Ryan, Maral DerSarkissian, Akanksha Dua, Christopher Yee, Mei Sheng Duh, Jorge E. Gomez
Comparison of baseline characteristics of unresected, stage III NSCLC patients treated with systemic therapy, radiotherapy, and concurrent chemoradiotherapy1,2.